(NASDAQ: HOLX) Hologic's forecast annual revenue growth rate of 5.96% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 7.91%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.81%.
Hologic's revenue in 2025 is $4,100,500,000.On average, 22 Wall Street analysts forecast HOLX's revenue for 2026 to be $975,210,372,500, with the lowest HOLX revenue forecast at $921,936,023,008, and the highest HOLX revenue forecast at $1,010,652,303,752. On average, 19 Wall Street analysts forecast HOLX's revenue for 2027 to be $1,031,159,584,728, with the lowest HOLX revenue forecast at $982,120,434,568, and the highest HOLX revenue forecast at $1,070,390,904,856.
In 2028, HOLX is forecast to generate $1,087,554,607,412 in revenue, with the lowest revenue forecast at $1,028,484,721,992 and the highest revenue forecast at $1,137,262,473,256.